Breast Cancer, Cancer of the Breast
Conditions
Keywords
Breast cancer screening, Mammography, Black women, Disparities, No-show rates
Brief summary
The purpose of this study is to increase screening mammography among Black women by implementing and evaluating a culturally tailored patient-centric program designed to address barriers to screening. By performing a randomized clinical trial, this study aims to develop effective strategies to improve adherence to screening mammography and contribute to reducing health disparities in breast cancer outcomes.
Interventions
OTHERAppointment mail reminder
Patient will receive an appointment reminder in the mail 7-10 days prior to the appointment.
OTHERTelephone counseling
The telephone counseling will include an appointment reminder within 7 days of their appointment and identify and troubleshoot barriers to patient's mammography completion.
OTHERDigital navigation video
The digital navigation video will explain the rationale for the mammogram and the mammography procedure. Digital navigation video will be sent by SMS text message 1-3 days prior to the appointment.
OTHERAutomated phone call
Patient will receive an automated reminder phone call for their appointment 1-3 days prior to the appointment.
Sponsors
Washington University School of Medicine
National Comprehensive Cancer Network
Novartis
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Woman * At least 40 years old * Self-identify as Black * English-speaking * Scheduled for a screening mammogram within 8 weeks of study entry * Able to understand and willing to sign an IRB approved written informed consent document.
Exclusion criteria
* A previous history of breast cancer * Scheduled for a diagnostic mammogram * Has a documented or uncorrectable cognitive, hearing, or visual impairment. * Too ill to participate (diagnosed with or suffering from a condition that, in the judgment of the investigator, may limit participation in the study).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| No-show rate | 6 months after randomization | Defined as the proportion of participants who do not complete (or do not reschedule) their screening mammogram appointment within 6 months of randomization. |
Countries
United States
Contacts
CONTACTFoluso Ademuyiwa, MD, MPH, MSCI
PRINCIPAL_INVESTIGATORFoluso Ademuyiwa, MD, MPH, MSCI
Washington University School of Medicine
Outcome results
None listed